Breast cancer version 2.2015: Clinical practice guidelines in oncology

William J. Gradishar, Benjamin O. Anderson, Ron Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Matthew Goetz, Lori J. Goldstein, Clifford A. Hudis, Steven J. Isakoff, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Meena Moran, Sameer A. Patel, Lori J. PierceElizabeth C. Reed, Kilian E. Salerno, Lee S. Schwartzberg, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, George Somlo, Melinda Telli, John H. Ward, Dorothy A. Shead, Rashmi Kumar

Research output: Contribution to journalReview article

128 Scopus citations

Abstract

Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The overall management of breast cancer includes the treatment of local disease with surgery, radiation therapy, or both, and the treatment of systemic disease with cytotoxic chemotherapy, endocrine therapy, biologic therapy, or combinations of these. This portion of the NCCN Guidelines discusses recommendations specific to the locoregional management of clinical stage I, II, and IIIA (T3N1M0) tumors.

Original languageEnglish (US)
Pages (from-to)448-475
Number of pages28
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume13
Issue number4
DOIs
StatePublished - Apr 1 2015

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Breast cancer version 2.2015: Clinical practice guidelines in oncology'. Together they form a unique fingerprint.

  • Cite this

    Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., Goetz, M., Goldstein, L. J., Hudis, C. A., Isakoff, S. J., Marcom, P. K., Mayer, I. A., McCormick, B., Moran, M., Patel, S. A., ... Kumar, R. (2015). Breast cancer version 2.2015: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 13(4), 448-475. https://doi.org/10.6004/jnccn.2015.0060